CINECA IRIS Institutional Research Information System

LOPIANO, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.349
EU - Europa 17.598
AS - Asia 14.615
SA - Sud America 2.125
AF - Africa 327
OC - Oceania 247
Continente sconosciuto - Info sul continente non disponibili 11
Totale 60.272
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.426
IT - Italia 6.855
SG - Singapore 5.253
CN - Cina 4.179
BR - Brasile 1.622
DE - Germania 1.570
FR - Francia 1.509
VN - Vietnam 1.462
IE - Irlanda 1.297
SE - Svezia 1.214
GB - Regno Unito 918
FI - Finlandia 869
JP - Giappone 709
KR - Corea 648
CA - Canada 610
UA - Ucraina 522
IN - India 495
ES - Italia 464
HK - Hong Kong 464
AT - Austria 459
NL - Olanda 410
PL - Polonia 352
BD - Bangladesh 282
AU - Australia 224
AR - Argentina 204
RU - Federazione Russa 193
ID - Indonesia 171
TR - Turchia 170
MX - Messico 167
BE - Belgio 161
IQ - Iraq 120
PT - Portogallo 119
CH - Svizzera 117
TW - Taiwan 104
GR - Grecia 103
ZA - Sudafrica 91
DK - Danimarca 79
EC - Ecuador 67
PK - Pakistan 64
RO - Romania 59
CO - Colombia 58
CL - Cile 56
SA - Arabia Saudita 54
UZ - Uzbekistan 49
IL - Israele 48
EG - Egitto 47
JM - Giamaica 47
CZ - Repubblica Ceca 43
TH - Thailandia 41
MA - Marocco 39
PE - Perù 38
BG - Bulgaria 36
MY - Malesia 35
IR - Iran 32
NO - Norvegia 32
TN - Tunisia 32
AE - Emirati Arabi Uniti 31
PH - Filippine 31
LT - Lituania 28
RS - Serbia 27
PY - Paraguay 25
SN - Senegal 25
VE - Venezuela 25
AL - Albania 23
JO - Giordania 22
NZ - Nuova Zelanda 22
HR - Croazia 21
UY - Uruguay 21
NP - Nepal 20
SI - Slovenia 20
CR - Costa Rica 18
KE - Kenya 17
LB - Libano 17
BY - Bielorussia 15
SK - Slovacchia (Repubblica Slovacca) 15
AZ - Azerbaigian 14
DZ - Algeria 14
HU - Ungheria 14
OM - Oman 14
HN - Honduras 13
KZ - Kazakistan 12
NG - Nigeria 12
DO - Repubblica Dominicana 11
LU - Lussemburgo 11
CI - Costa d'Avorio 10
ET - Etiopia 10
PA - Panama 10
SV - El Salvador 10
GE - Georgia 9
SY - Repubblica araba siriana 9
CY - Cipro 8
EE - Estonia 8
MD - Moldavia 8
NI - Nicaragua 8
BA - Bosnia-Erzegovina 7
BO - Bolivia 7
LV - Lettonia 7
TT - Trinidad e Tobago 7
EU - Europa 6
GA - Gabon 6
Totale 60.157
Salva come PNG Salva come JPEG
Città #
Singapore 2.972
Beijing 2.040
Chandler 1.963
San Jose 1.925
Ashburn 1.766
Santa Clara 1.384
Dublin 1.265
Houston 1.252
Fairfield 807
Milan 807
Torino 663
Dallas 647
Rome 524
Ann Arbor 514
Villeurbanne 483
Turin 471
Wilmington 471
Nyköping 421
Princeton 420
Redwood City 420
Ho Chi Minh City 405
Jacksonville 399
Woodbridge 399
Medford 395
Los Angeles 388
Vienna 388
Columbus 385
Hong Kong 362
Lauterbourg 359
Seattle 344
The Dalles 338
Dearborn 313
Cambridge 297
Warsaw 293
Helsinki 292
Hanoi 285
Seoul 266
Munich 259
Buffalo 246
New York 245
Boston 239
Tokyo 227
Hefei 222
São Paulo 177
Pisa 171
Dong Ket 161
Boardman 152
Shanghai 143
Frankfurt am Main 130
Guangzhou 128
Madrid 128
Ottawa 126
Naples 118
Verona 118
Bologna 117
London 110
Jakarta 109
Toronto 104
Orem 96
Council Bluffs 95
Nanjing 89
Hangzhou 83
Brussels 82
Amsterdam 80
Florence 80
Palermo 80
Atlanta 78
Phoenix 74
Chicago 73
Redondo Beach 73
Düsseldorf 72
Fremont 72
Washington 72
Bengaluru 71
Catania 70
Paris 70
Chengdu 69
Taipei 66
Sydney 65
Duncan 63
Montreal 63
Turku 61
Norwalk 60
Bari 57
Da Nang 54
Nuremberg 54
Johannesburg 53
Wuhan 51
Istanbul 50
Brooklyn 49
Haiphong 49
Rio de Janeiro 48
San Diego 47
Denver 46
Mumbai 46
Stockholm 46
Memphis 44
Silver Spring 43
Barcelona 42
Chennai 42
Totale 33.231
Salva come PNG Salva come JPEG
Nome #
Early DEtection of wEaring off in Parkinson disease: The DEEP study 1.925
Il Bergamini di Neurologia 1.529
Validation of the Italian version of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale. 1.082
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. 920
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 848
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 772
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study. 732
Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study 642
Subcutaneous vs intravenous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an Italian cost-minimization analysis 627
Network Analysis Identifies Disease-Specific Pathways for Parkinson’s Disease 605
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience 544
Levodopa-carbidopa intestinal gel infusion and weight loss in Parkinson's disease 536
Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy? 528
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. 514
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 482
Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study. 429
Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder 426
Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients 410
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy 410
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome? 391
Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease 380
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements. 377
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. 372
Three novel missense mutations in SLC20A2 associated with idiopathic basal ganglia calcification 369
Deep Brain Stimulation of the subthalamic nucleus does not negatively affect social cognitive abilities of patients with Parkinson's disease 364
Gut microbiota and metabolome distinctive features in parkinson disease: Focus on levodopa and levodopa carbidopa intrajejunal gel 351
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset? 346
Self-unawareness of levodopa induced dyskinesias in patients with Parkinson's disease. 333
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients 327
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 288
Emotion Processing in Parkinson’s Disease: A Three-Level Study on Recognition, Representation, and Regulation 284
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 283
Teaching neurons to respond to placebos 281
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 279
Alessitimia e depressione in pazienti con malattia di Parkinson sottoposti a deep brain stimulation del subtalamo: uno studio caso-controllo. 271
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 245
When words are painful: unraveling the mechanisms of the nocebo effect 243
Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease 242
Alexithymia in patients with Parkinson's disease treated with DBS of the subthalamic nucleus: a case-control study 236
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. 236
Cleptomania associata a terapia con dopaminoagonista in un paziente affetto da malattia di Parkinson 228
Neurological comorbidity and severity of COVID-19 222
Stimulation of the subthalamic area modulating movement and behavior 221
Impulsivities and Parkinson's disease: Delay aversion is not worsened by Deep Brain Stimulation of the Subthalamic Nucleus 218
Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment. 215
Analisi dei costi della stimolazione cerebrale profonda (DBS) nella malattia di Parkinson: uno studio osservazionale su pazienti italiani. 212
Motor and non-motor outcomes in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study 210
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment 208
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review 202
Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra. 201
What Happens When I Watch a Ballet and I Am Dyskinetic? A fMRI Case Report in Parkinson Disease. 199
Open versus hidden medical treatments: the patient's knowledge about a therapy affects the therapy outcome. 198
Analysis of CHCHD2 and CHCHD10 genes in patients with Parkinson’s disease and mitochondrial myopathy. 192
Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response 191
Alpha-Synuclein protects SH-SY5Y cells from dopamine toxicity 187
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study 185
Narrative abilities in Parkinson's disease:A pilot study on italian-speaking patients treated with deep brain stimulation of the subthalamic nucleus 183
Effectiveness of a dance-physiotherapy combined intervention in Parkinson's disease: a randomized controlled pilot trial 179
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age 178
Antiparkinsonian therapy modifications in PD patients after STN DBS: A retrospective observational analysis 176
Sleep microstructure in Parkinson's disease: cycling alternating pattern (CAP) as a sensitive marker of early NREM sleep instability 176
Nuclear magnetic resonance spectroscopy characterization and iron content determination of human mesencephalic neuromelanin. 175
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 175
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 174
Restricted dissociated sensory loss in a patient with a lateral medullary syndrome: A clinical-MRI study. 173
Role of the cingulate cortex in dyskinesias-reduced-self-awareness: An fMRI study on Parkinson's disease patients 173
Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study 173
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 173
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 173
Personality and Deep Brain Stimulation of the subthalamic nucleus in Parkinson's disease 172
Stretch reflex of quadriceps femoris and its relation to rigidity in Parkinson's disease. 170
Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients 170
Apathy and verbal fluency in STN-stimulated PD patients: An observational follow-up study 169
An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation 168
Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside 167
Apathy and verbal fluency in STN-stimulated PD patients 164
AN ORIGINAL STUDY OF MASTICATION IN PATIENTS WITH ADVANCED PARKINSON DISEASE WITH AND WITHOUT ME- DICAL THERAPY AND DEEP BRAIN STIMULATION 161
Unawareness of dyskinesias in Parkinson’s Disease: Is there a relationship with Theory of Mind dysfunctions? 161
Consensus on the treatment of dysphagia in Parkinson's disease 161
Deep brain stimulation in Parkinson's disease: comparison of pre- and post-operative neuropsychological evaluation 160
Apatia in pazienti con malattia di Parkinson sottoposti a DBS del nucleo subtalamico. 160
Deep brain stimulation of subthalamic nucleus: behavioral modifications and familiar relations 156
NADPH Oxidases (NOX) Enzymes Induced Oxidative Stress in CIDP Patients 155
Novel parkin mutations detected in patients with early-onset Parkinson's disease 155
Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study 155
A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion 154
Neuropsychological changes 1-year after subthalamic DBS in PD patients: a prospective controlled study 153
Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease. 152
Dysphagia predicts poor outcome in late-stage Parkinson's disease 152
Macro- and Micro-Structural Aspects of Sleep in Severe Parkinson's Disease 152
Deep brain stimulation of the subthalamic nucleus in PD: an analysis of the exclusion causes 151
Beyond Nine Years of Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease 151
3 years comparison between duodopa and Deep Brain Stimulation 151
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value 151
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study 150
The dominant-subthalamic nucleus phenomenon in bilateral deep brain stimulation for Parkinson's disease: Evidence from a gait analysis study 150
An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation. 148
Cognitive Reserve in ALS with Comorbid Frontotemporal Dementia (FTD): A Population-Based Study 148
Advanced therapies in Parkinson's disease: Long-term retrospective study 147
Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. 146
Totale 30.889
Salva come PNG Salva come JPEG
Categoria #
all - tutte 175.222
article - articoli 0
book - libri 0
conference - conferenze 21.639
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 196.861
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.446 231 179 208 428 234 229 269 225 202 343 958 940
2022/20236.232 686 524 200 605 599 1.515 458 371 594 189 321 170
2023/20243.087 328 523 151 213 260 332 122 211 45 225 254 423
2024/20258.877 199 487 304 788 1.944 726 437 601 889 602 699 1.201
2025/202619.739 1.728 839 1.448 2.081 1.926 947 2.412 866 1.447 1.885 979 3.181
2026/2027222 222 0 0 0 0 0 0 0 0 0 0 0
Totale 61.600